Pilot study of a dose-adjusted regimen of tiroban during percutnaeous coronary intervention

Trial Profile

Pilot study of a dose-adjusted regimen of tiroban during percutnaeous coronary intervention

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 14 Jul 2014

At a glance

  • Drugs Tirofiban (Primary)
  • Indications Acute coronary syndromes
  • Focus Adverse reactions
  • Most Recent Events

    • 14 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top